The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

Blue Cross plans are retreating from GLP-1 weight-loss drug coverage after spending hundreds of millions of dollars on the ...

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

Evernorth, the health services division of The Cigna Group (NYSE: CI) announced a first-of-its-kind pharmacy benefit offering that make weight loss medications WEGOVY® and ZEPBOUND® more ...

Are you weening yourself off a compounded version of the drug? Considering switching insurers in order to keep your ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

Meanwhile, the Danish drugmaker was also bolstered by the decision by pharmacy benefit manager (PBM) CVS Health to remove Zepbound but retain Wegovy on its formulary of reimbursed medicines.

Shares in Eli Lilly have weakened after CVS Health, one of the largest pharmacy benefit managers ... Health has retained coverage of Zepbound's arch rival Wegovy (semaglutide), sold by Novo ...